Hospices Civils de Lyon: Hepatitis trials
The registry lists 12 Hepatitis studies with Hospices Civils de Lyon as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 3 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic SteatohepatitisRecruitingNCT06152250Not applicable
- Lyon Granulomatous Hepatitis StudyStatus unknownNCT04459897
- Side Effects After Direct-acting Antiviral TreatmentCompletedNCT03346941
- Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed CryoglobulinemiaCompletedNCT03342261
- Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNACompletedNCT03318887
- Direct-acting Antivirals and Hepatocellular Carcinoma RecurrenceCompletedNCT03197155
- Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or CuredCompletedNCT02909023
- Ribavirin Bioavailability After Telaprevir ExposureCompletedNCT02881034
- Anti-E1E2 Antibodies (D32.10 Epitope-binding Antibodies) and HCV Triple TherapyCompletedNCT02877199
- Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence StudyStatus unknownNCT02809885Not applicable
- Role of FXR in Hepatitis C Virus ReplicationTerminatedNCT01492998Not applicable
- RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of RibavirinStatus unknownNCT00485342Phase 3